Drug intelligence / Profile preview

miR-7 loaded exosomes

Development stage
Preclinical
Modality
RNA Therapeutics → Nucleic Acid Therapeutics, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intravenous, Intratumoral
01

Overview

miR-7 loaded exosomes are an experimental therapeutic modality utilizing extracellular vesicles (exosomes) to deliver microRNA-7 (miR-7) to target cells, primarily for the treatment of various cancers such as glioblastoma and pancreatic adenocarcinoma. miR-7 is a potent tumor suppressor that downregulates multiple oncogenic signaling pathways by binding to the 3' untranslated regions (UTRs) of target mRNAs, including EGFR, IGF-1R, and members of the PI3K/Akt pathway. By encapsulating miR-7 within exosomes—often derived from mesenchymal stem cells (MSCs) or engineered donor cells—the microRNA is protected from degradation in the systemic circulation and can be delivered with enhanced bioavailability and potentially reduced immunogenicity compared to synthetic nanoparticles. This approach aims to restore miR-7 levels in tumors where it is frequently downregulated, thereby inhibiting cell proliferation, migration, and angiogenesis.

Other names
miR-7-loaded exosomesmiR7-loaded exosomesmiR 7-loaded exosomesexosomal miR-7MSC-derived miR-7 exosomes
02

Targets

IRS1 (Insulin receptor substrate 1)PAK1 (p21-activated kinase 1)IGF-1R (Insulin-like growth factor 1 receptor)

Beyond the preview

Go deeper on miR-7 loaded exosomes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on miR-7 loaded exosomes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call